PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Celltrion to Present New Analyses of ZYMFENTRA® (infliximab-dyyb) in Crohn's Disease and Ulcerative Colitis at ACG 2026
2026-10-12T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™
2026-10-10T    Biotechnology   Computer/Electronics   Health Care/Hospital   Infectious Disease Control 
Antengene to Present Latest Preclinical Results of ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at ACR 2026
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Telix to Host Capital Markets Day in Melbourne on November 4, 2026
2026-10-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
GenScript Launches Life Sciences Startup PitchFest with NVIDIA to Accelerate Biotech Innovation
2026-10-08T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SECuRE update: recruitment target of the Cohort Expansion Main Group achieved
2026-10-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology
2026-10-08T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.